Psychiatrie und Psychotherapie up2date, Inhaltsverzeichnis Psychiatrie und Psychotherapie up2date 2012; 6(04): 293-308DOI: 10.1055/s-0032-1304958 Essstörungen, somatische Belastungsstörungen, Schlafstörungen und sexuelle Funktionsstörungen Funktionelle gastrointestinale Störungen Claas Lahmann , Winfried Häuser , Andreas Dinkel Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Volltext Referenzen Literatur 1 Häuser W, Layer P, Henningsen P. et al. Funktionelle Darmbeschwerden bei Erwachsenen. Dtsch Arzteblatt Int 2012; 109: 83-93 2 Andresen V, Keller J, Pehl C. et al. Reizdarmsyndrom – die wichtigsten Empfehlungen. Dtsch Arztebl Int 2011; 108: 751-760 3 Spiegel BMR, Farid M, Esrailian E. et al. Is irritable bowel syndrome a diagnosis of exclusion? A survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010; 105: 848-858 4 Khan AA, Khan A, Harezlak J. et al. Somatic symptoms in primary care: etiology and outcome. Psychosomatics 2003; 44: 471-478 5 Mussell M, Kroenke K, Spitzer RL. et al. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. J Psychosom Res 2008; 64: 605-612 6 Hiller W, Rief W, Brähler E. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 2006; 41: 704-712 7 Chang L, Toner BB, Fukudo S. et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1435-1446 8 Halder S, Macfarlane GJ, Thompson D. et al. Predictors of persistent gastrointestinal symptoms among new presenters to primary care. Eur J Gastroenterol Hepatol 2010; 22: 296-305 9 Halder SLS, Locke III GR, Schleck CD. et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007; 133: 799-807 10 Koloski NA, Talley NJ, Boyce PM. Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community cohort study. Am J Gastroenterol 2003; 98: 789-797 11 Drossman DA. The functional gastrointestinal disorders and the ROME III process. Gastroenterology 2006; 130: 1377-1390 12 Dilling H, Mombour W, Schmidt MH. Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien. Bern: Huber; 2008 13 Saß H, Wittchen HU, Zaudig M. et al. Diagnostisches und Statistisches Manual Psychischer Störungen – Textrevision. DSM-IV-TR. Göttingen: Hogrefe; 2003 14 Lahmann C, Henningsen P, Dinkel A. Somatoforme und funktionelle Störungen. Nervenarzt 2010; 81: 1383-1396 15 Gamiche JP, Clouse RE, Bálint A. et al. Functional esophageal disorders. Gastroenterology 2006; 130: 1459-1465 16 Tack J, Talley NJ, Camilleri M. et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479 17 Choung RS, Locke III GR. Epidemiology of IBS. Gastroenterol Clin N Am 2011; 40: 1-10 18 Longstreth GF, Thompson WG, Chey WD. et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [Correction: Gastroenterology 2006; 131: 688]. 19 American College of Gastroenterology IBS Task Force. An evidence-based systematic review on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104: S1-S35 20 Bharucha AE, Wald A, Enck P. et al. Functional anorectal disorders. Gastroenterology 2006; 130: 1510-1518 21 Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002; 122: 1140-1156 22 Riedl A, Schmidtmann M, Stengel A. et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008; 64: 573-582 23 Farrokhyar F, Marshall JK, Easterbrook B. et al. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006; 12: 38-46 24 Bryant RV, van Langenberg DR, Holtmann GJ. et al. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol 2011; 26: 916-923 25 Ford AC, Marwaha A, Lim A. et al. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol 2010; 8: 401-409 26 Blanchard EB, Keefer L, Lackner JM. et al. The role of childhood abuse in axis I and axis II psychiatric disorders and medical disorders of unknown origin among irritable bowel syndrome patients. J Psychosom Res 2004; 56: 431-436 27 North CS, Downs D, Clouse RE. et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2: 787-795 28 Mykletun A, Jacka F, Williams L. et al. Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women. BMC Gastroenterol 2010; 10: 88 29 Boyd C, Abraham S, Kellow J. Appearance and disappearance of functional gastrointestinal disorders in patients with eating disorders. Neurogastroenterol Motil 2010; 22: 1279-1283 30 Janssen P. Can eating disorders cause functional gastrointestinal disorders?. Neurogastroenterol Motil 2010; 22: 1267-1269 31 Gros DF, Antony MM, McCabe RE. et al. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord 2009; 23: 290-296 32 Masand PS, Keuthen NJ, Gupta S. et al. Prevalence of irritable bowel syndrome in obsessive-compulsive disorder. CNS Spectr 2006; 11: 21-25 33 Locke GR III, Weaver AL, Melton III LJ. et al. Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol 2004; 99: 350-357 34 Bijkerk CJ, de Wit NJ, Muris JWM. et al. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 2003; 98: 122-127 35 Lahmann C, Dinkel A. Diagnostik bei somatoformen Störungen und chronischem Schmerz. Psychother Dialog 2012; 13: 41-45 36 Layer P, Andresen V, Pehl C. et al. S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Z Gastroenterol 2011; 49: 237-293 37 Spiller R, Aziz Q, Creed F. et al. Guidelines on the irritable bowel syndrome. Mechanisms and practical management. Gut 2007; 56: 1770-1798 38 Chitkara DK, van Tilburg MA, Blois-Martin N. et al. Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol 2008; 103: 765-774 39 Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007; 369: 946-955 40 Miwa H, Nagahara A, Tominaga K. et al. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial. Am J Gastroenterol 2009; 104: 2779-2787 41 Brun R, Kuo B. Functional dyspepsia. Ther Adv Gastronterol 2010; 3: 145-164 42 Hojo M, Miwa H, Yokoyama T. et al. Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol 2005; 40: 1036-1042 43 Ford AC, Talley NJ, Schoenfeld PS. et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009; 58: 367-378 44 Moss-Morris R, McAlpine L, Didsbury LP. et al. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Psychol Med 2010; 40: 85-94 45 Ljótsson B, Andersson G, Andersson E. et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol 2011; 11: 110 46 Kearney DJ, McDermott K, Martinez M. et al. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety, and quality of life. Aliment Pharmacol Ther 2011; 34: 363-373 47 Chiarioni G, Whitehead WE. The role of biofeedback in the treatment of gastrointestinal disorders. Nat Clin Practice Gastroenterol Hepatol 2008; 5: 371-382 48 Collins J, Farrall E, Turnbull DA. et al. Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disorders. Clin Gastroenterol Hepatol 2009; 7: 1252-1254 49 Martens U, Enck P, Matheis A. et al. Motivation for psychotherapy in patients with functional gastrointestinal disorders. Psychosomatics 2010; 51: 225-229 50 Arbeitskreis PISO. Hrsg. Somatoforme Störungen. Psychodynamisch-Interpersonelle Therapie (PISO). Göttingen: Hogrefe; 2012
